According to data from real-time TV ad tracker iSpot.tv, fifteen prescription drug brand ads ran 221 times on national TV during the February run of the PyeongChang games on NBC. This represented 4.1% Spend Share of the Voice for all ads running during the Olympics.
The top three ads came from Merck and Pfizer. Merck spent $11.3 million on cancer drug Keytruda. Meanwhile, Pfizer at the Olympics spent $10.9 million on commercials for its metastatic breast cancer treatment Ibrance and another $8.3 million on a Xeljanz XR spot for its rheumatoid arthritis indication.
Click here to view the entire article.